About Ranbaxy Laboratories Ltd
Data last updated:
Ranbaxy Laboratories Ltd was a public limited company based in Mohali, Punjab, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 June 1961.
The company was registered with the Registrar of Companies (ROC), Chandigarh, under CIN L24231PB1961PLC003747. It is a listed company.
The company had an authorised share capital of ₹300 Cr and a paid-up capital of ₹212.83 Cr. It was led by directors including Arun Sawhney (Managing Director) and Rajesh Viren Shah.
Its last annual general meeting (AGM) was held on 28 July 2014, and its latest financial statements are for the year ended 31 March 2014. The registered office was at A – 41 Industrial Area Phase VIII – A, Mohali, Punjab, India – 160071.
As per the financials filed for FY 2014, the company reported a revenue of ₹1.35 Lakh, a growth of 5% compared to the previous year.
The company was associated with 1 brand: Ranbaxy Laboratories. As per MCA filings, the company had satisfied charges of ₹23.05 Cr on record. Court records list 631 cases involving the company, including 357 filed by the company and 274 filed against it; 57 cases are pending. The company has 5 deals on record (4 acquisitions, 1 market trade); the latest was in March 2015. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Allegro Remedies Private Limited with revenue of ₹1.41 Lakh.
The last known website on record is ranbaxy.com.
CIN History of Ranbaxy Laboratories Ltd
Ranbaxy Laboratories has one previous CIN (Corporate Identification Number): U24231PB1961PLC003747. The current CIN is L24231PB1961PLC003747, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24231PB1961PLC003747 | Current |
| U24231PB1961PLC003747 | Previous |
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressA – 41 Industrial Area Phase VIII – A, Mohali, Punjab, India – 160071
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Ranbaxy Laboratories Ltd
Ranbaxy Laboratories operates one associated brand: Ranbaxy Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A well-diversified pharma company manufacturing & marketing range of pharmaceutical products | ranbaxy.com |
Financials of Ranbaxy Laboratories Ltd FY 2014 filings available
Ranbaxy Laboratories Ltd reported revenue of ₹1.35 Lakh (up 5% YoY) for FY 2014.
Compounded Annual Growth Rate (CAGR) of Ranbaxy Laboratories Ltd
Revenue rose 5% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Ranbaxy Laboratories Ltd
| Metrics | FY 2013-14 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | •••• |
| Other Income | •••• |
| Total Revenue | •••• |
| Cost of Materials Consumed | •••• |
| Employee Benefit Expense | •••• |
| Finance Costs | •••• |
| Depreciation and Amortisation | •••• |
| Other Expenses | •••• |
| Total Expenses | •••• |
| EBITDA | •••• |
| Profit Before Tax | •••• |
| Tax Expense | •••• |
| Net Profit (PAT) | •••• |
| Balance Sheet | |
| Share Capital | •••• |
| Reserves and Surplus | •••• |
| Net Worth (Total Equity) | •••• |
| Long-term Borrowings | •••• |
| Short-term Borrowings | •••• |
| Trade Payables | •••• |
| Total Liabilities | •••• |
| Fixed Assets | •••• |
| Investments | •••• |
| Inventories | •••• |
| Trade Receivables | •••• |
| Cash and Bank Balance | •••• |
| Total Assets | •••• |
Financial Ratios of Ranbaxy Laboratories Ltd
| Metrics | FY 2013-14 |
|---|---|
| Profitability | |
| EBITDA Margin | •••• |
| Net Profit Margin | •••• |
| Return on Equity (ROE) | •••• |
| Return on Capital Employed (ROCE) | •••• |
| Return on Assets (ROA) | •••• |
| Liquidity and Debt | |
| Current Ratio | •••• |
| Quick Ratio | •••• |
| Debt-to-Equity Ratio | •••• |
| Interest Coverage Ratio | •••• |
| Efficiency and Growth | |
| Asset Turnover | •••• |
| Receivable Days | •••• |
| Payable Days | •••• |
| Inventory Days | •••• |
| Revenue Growth | •••• |
| Net Profit Growth | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ranbaxy Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors and KMP of Ranbaxy Laboratories Ltd
Ranbaxy Laboratories Ltd currently reports 8 directors and 1 key managerial person. 18 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Viren Shah | Director | 29 May 2009 | 17 Years 4 Months | As last reported |
| Akihiro Watanabe | Director | 09 May 2011 | 15 Years 5 Months | As last reported |
| Arun Sawhney Also directs: Granules India Limited | Managing Director | 09 May 2011 | 15 Years 5 Months | As last reported |
| Percy Keku Shroff | Director | 27 Mar 2009 | 17 Years 6 Months | As last reported |
| Takashi Shoda | Director | 19 Dec 2008 | 17 Years 10 Months | As last reported |
| Tsutomu Une | Director | 10 May 2010 | 16 Years 5 Months | As last reported |
Peer Comparison of Ranbaxy Laboratories Ltd
Ranbaxy Laboratories Ltd is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Allegro Remedies Private Limited | ₹1.41 Lakh (FY 2025) | •••• | •••• | -73.0% | •••• | Delhi, India |
| Clini Vigil Pharma Solutions Private Limited | ₹1.39 Lakh (FY 2021) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Zed Life Sciences Private Limited | ₹1.38 Lakh (FY 2020) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Innocure Pharma Private Limited | ₹1.35 Lakh (FY 2025) | •••• | •••• | 62.0% | •••• | Tiruvannamalai, Tamil Nadu, India |
| Gayatri Pharmaceuticals Pvt Ltd | ₹1.35 Lakh (FY 2025) | •••• | •••• | -24.0% | •••• | Cuttack, Odisha, India |
| Ranbaxy Laboratories Ltd this company | ₹1.35 Lakh (FY 2014) | •••• | •••• | 5.0% | •••• | Mohali, Punjab, India |
| Athachi Wellness Solutions Private Limited | ₹1.34 Lakh (FY 2025) | •••• | •••• | 173.0% | •••• | Palakkad, Kerala, India |
| Harwell Lifesciences Private Limited | ₹1.33 Lakh (FY 2021) | •••• | •••• | -80.0% | •••• | Bangalore, Karnataka, India |
| Silva Pharmaceuticals Private Limited | ₹1.3 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Kolkata, West Bengal, India |
| Globax Healthcare Private Limited | ₹1.3 Lakh (FY 2024) | •••• | •••• | -66.0% | •••• | Noida, Uttar Pradesh, India |
| Bonsai Pharmachem Limited | ₹1.3 Lakh (FY 2025) | •••• | •••• | -1.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Ranbaxy Laboratories by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Ranbaxy Laboratories Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jul 1994 | Bank of America | ₹23.05 Cr | Satisfied |
Total charge records: 1 View all charges
Deals & Funding of Ranbaxy Laboratories Ltd
Ranbaxy Laboratories Ltd has 5 deals on record (4 acquisitions, 1 market trade); the latest was in March 2015.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2015 | Acquisition | Undisclosed | Buyer: Emcure Pharmaceuticals Limited Seller: Ranbaxy Laboratories Ltd |
| Apr 2014 | Acquisition | ₹24,128 Cr | Buyer: Sun Pharmaceutical Industries Limited Seller: Daiichi Sankyo Company |
| Dec 2009 | Acquisition | ₹63.97 Cr | Buyer: HNG Chembio Pharmacy Co. Ltd. Seller: Ranbaxy Laboratories Ltd |
| Jun 2008 | Acquisition | ₹17,456 Cr | Buyer: Daiichi Sankyo Company Ltd. |
| Mar 2006 | Market trade | ₹330.68 Cr | Buyer: Ubs Securities Asia Ltd. Seller: an individual |
Full deal history
All 5 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Ranbaxy Laboratories Ltd
Ranbaxy Laboratories Ltd has 631 court cases on record: 357 filed by Ranbaxy Laboratories, 274 filed against it. 57 cases are pending and 574 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 414 | 156 | 49 |
| District courts | 178 | 95 | 8 |
| Supreme Court | 39 | 23 | 0 |
Cases on record (5 of 631)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (C.O. (COMM.IPD-TM)) | Filed against the company by Medley Pharmaceuticals Ltd | Pending |
| High Court of Delhi | Commercial suit | Filed by the company against M/S Intas Pharmaceuticals Ltd & Ors. | Pending |
| High Court, CHANDIGARH (UT) | Court case (OLR) | Filed by the company against M/S Haryana Drugs and Pharmaceuticals Limited | Disposed |
| District court, Vadodara, Gujarat | Civil suit | Filed by the company against Gama Exports Pvt. Ltd. and 1 other | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (S S) | Filed by the company against Revive Hospital Supply Pvt. Ltd. and 1 other | Disposed |
Full case history
All 631 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Ranbaxy Laboratories Ltd
Employment history and EPFO contributions of people linked to Ranbaxy Laboratories.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ranbaxy Laboratories Ltd
Ranbaxy Laboratories Ltd has 43 board changes on record since 1992: 26 appointments and 17 cessations. The latest: Kazunori Hirokawa was appointed as Director on 09 May 2012.
37 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Ranbaxy Laboratories Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ranbaxy Laboratories Ltd
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ranbaxy Laboratories Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ranbaxy Laboratories Ltd
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ranbaxy Laboratories Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Ranbaxy Laboratories Ltd
Articles about Ranbaxy Laboratories Ltd on our blog
- Top 5 Pharma Companies in India-202126 Feb 2021
Frequently Asked Questions about Ranbaxy Laboratories Ltd
Ranbaxy Laboratories has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Ranbaxy Laboratories was a public limited company based in Mohali, Punjab, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 16 June 1961 and is registered under CIN L24231PB1961PLC003747. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Ranbaxy Laboratories was incorporated on 16 June 1961. It is registered with the Registrar of Companies, Chandigarh.
Ranbaxy Laboratories had 9 directors and KMP:
- Arun Sawhney - Managing Director
- Rajesh Viren Shah - Director
- Akihiro Watanabe - Director
- Percy Keku Shroff - Director
- Takashi Shoda - Director
- Tsutomu Une - Director
- Anthony Hugh Wild - Director
- Kazunori Hirokawa - Director
- Sushil Kumar Patawari - Company Secretary
The CIN (Corporate Identification Number) of Ranbaxy Laboratories is L24231PB1961PLC003747. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes, Ranbaxy Laboratories is a listed company.
The registered office of Ranbaxy Laboratories is at A – 41 Industrial Area Phase VIII – A, Mohali, Punjab, India – 160071.
Ranbaxy Laboratories can be reached through the website ranbaxy.com. Its registered office is in Mohali, Punjab, India.
Ranbaxy Laboratories reported revenue of ₹1.35 Lakh for FY 2014 (up 5% YoY).
Ranbaxy Laboratories has an authorised share capital of ₹300 Cr and a paid-up capital of ₹212.83 Cr.
Ranbaxy Laboratories operated in the pharma industry, in the drug formulation and development segment.